Financhill
Sell
34

IAS Quote, Financials, Valuation and Earnings

Last price:
$10.34
Seasonality move :
-6.23%
Day range:
$10.34 - $10.34
52-week range:
$6.26 - $11.43
Dividend yield:
0%
P/E ratio:
37.05x
P/S ratio:
2.93x
P/B ratio:
1.57x
Volume:
--
Avg. volume:
1.2M
1-year change:
-1.16%
Market cap:
$1.7B
Revenue:
$530.1M
EPS (TTM):
$0.28

IAS Analysts' Consensus Rating

The 8 analysts providing 12-month price projections for Integral Ad Science Holding Corp. shares anticipate an average target of $10.67, ranging from a low estimate of $10.00 to a high estimate of $12.00. This average target implies a growth of 3.21% compared to the current stock price of $10.34.

Consensus Price Target

$10.67

Highest Price Target

$12.00

Lowest Price Target

$10.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 0 0

Hold 0 13 8

Sell 0 0 0
Consensus -- Hold Hold

IAS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 26

Travere Therapeutics, Inc. [TVTX] is down 1.29% over the past day.

Buy
68
KOD alert for Dec 26

Kodiak Sciences, Inc. [KOD] is down 5.28% over the past day.

Buy
64
ZCSH alert for Dec 23

Grayscale Zcash Trust (ZEC) [ZCSH] is down 0% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock